证券代码：002165 证券简称：红宝丽 公告编号：临 2026－015 红宝丽集团股份有限公司 关于第一大股东部分股份解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏 红宝丽集团股份有限公司（以下简称"公司"）近日接到第一大股东江苏宝 源投资管理有限公司（以下简称"宝源投资"）的函告，宝源投资因归还借款将 其所持有的公司股份1,060万股办理了解除质押登记手续，具体情况如下： | 股东 | 是否为第一 大股东及一 | 解除质押股 | 占其所 持股份 | 占公司 总股本 | 质押起始 | 解除质押 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | | 数(万股) | | | 日 | 日期 | 质权人 | | | 致行动人 | | 比例 | 比例 | | | | | 宝源 投资 | 是 | 1,060 | 7.42% | 1.44% | 2025 年 3 月 27 日 | 2026 年 3 月 23 日 | 宁波银行股份 有限公司南京 | | | | | | | | | 分行 | ...

红宝丽集团股份有限公司（以下简称"公司"）近日接到第一大股东江苏宝 源投资管理有限公司（以下简称"宝源投资"）的函告，宝源投资将其所持有的 公司950万股无限售股办理了质押登记手续，具体事项如下： 一、股东股份本次质押情况 宝源投资和招商证券股份有限公司（以下简称"招商证券"）于2026年3月 11日签署了《股票质押式回购交易业务协议》，宝源投资以持有的公司股份合计 950万股办理股票质押式回购初始质押融资。近日，宝源投资持有的公司股份950 万股的股票质押式回购初始质押登记手续已办理完毕，购回交易日为2027年3月 18日。具体如下： | 股 | 是否为 | 质押 | 本次质 | 占公 | 是否为 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 第一大 | | | | 限售股 | 是否为 | | | | | | 东 | | 股数 | 押占其 | 司总 | | | 质押开 | 质押到 | 质权 | | | 名 | 股东及 | （万 | 所持股 | 股本 | （如是， | 补充质 | 始日期 ...

值得注意的是，尽管上游油价走势强劲，但红宝丽目前并未实际生产环氧丙烷。21快讯记者以 投资者身份致电红宝丽，公司接线工作人员表示，股价波动属于市场行为， "公司产品价格正 常，没什么太大的变化。环氧丙烷还没有生产，还在做生产的前期准备，预计6月底之前恢复 生产。 " 记者丨 林健民 编辑丨叶映橙 3月6日，A股化工板块迎来集体爆发。截至收盘，红宝丽（002165.SZ）封死涨停板，报收 12.21元/股，成交额超9亿元，换手率超11%。作为环氧丙烷领域的"大牛股"，该股自年初以来 累计涨幅已超过60%。 | W | 红 宝 丽(002165) | | | | --- | --- | --- | --- | | | 闭市 03-06 15:00:00 融 通 | | | | 12.21 | 额 9.92亿 股本 7.35亿 市盈 "" | 180 | 万得 | | | | | 盘口 | | 1.11 10.00% 换 11.51% 市值 90亿 市净" | | 4.39 | | | 分时 | 五日 日Ｋ 周Ｋ 月Ｋ | 更多 ( | | | 叠加 | | 均价:11.84 盘口 | 资金 | | 12.21 | ...

Group 1: Financial Performance - Hengyu Environmental reported a revenue of 294 million yuan for 2025, an increase of 89.87%, and a net profit of 35.93 million yuan, up 106.25% [1] - Zhongke Shuguang achieved a revenue of 14.97 billion yuan in 2025, growing by 13.86%, with a net profit of 2.113 billion yuan, reflecting a 10.54% increase [2] - Oat Technology's revenue reached 619 million yuan, marking a 24.33% growth, and a net profit of 137 million yuan, up 42.63% [4] - Yongxi Electronics reported a revenue of 4.4 billion yuan, a 21.92% increase, with a net profit of 82.24 million yuan, up 23.99% [5] Group 2: Shareholder Actions - Yashida Optoelectronics announced that a shareholder plans to reduce holdings by up to 1.6 million shares, representing no more than 0.976% of the total share capital [3] - Yuanli Co. intends to repurchase shares worth 50 to 60 million yuan for employee stock ownership plans, with a maximum repurchase price of 20 yuan per share [6] - Conch Cement's controlling shareholder plans to increase holdings by 700 million to 1.4 billion yuan [7] - Huaneng Hydropower's controlling shareholder plans to increase holdings by 100 to 150 million yuan [8] Group 3: Corporate Announcements - Baotai's drug application for Darpobatin injection has been accepted by the National Medical Products Administration [14] - Changchun High-tech's subsidiary received approval for clinical trials of GenSci141 ointment [15] - Tongwei Co. is planning to acquire 100% of Lihua Qingneng, with stock trading suspended for up to 10 trading days [16] - Guoyao Modern's application for the raw material drug Minaprine has been approved [20] Group 4: Market Activities - Kaipu Cloud announced the termination of the acquisition of Nanning Taike [21] - Boji Pharmaceutical plans to reduce its holdings by up to 0.69% of the total share capital [23] - ST Renfu intends to issue shares to its controlling shareholder to raise 3 to 3.5 billion yuan for innovative drug development projects [24] - Huayi Technology submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [25]

Core Viewpoint - The company Hongbaoli (002165) announced that its Vice President, Tao Meijuan, plans to reduce her shareholding by up to 310,000 shares, representing no more than 0.04% of the total share capital, due to personal financial needs [1][2]. Shareholding Summary - Tao Meijuan currently holds 1,244,154 shares, which is 0.17% of the total share capital. The shares to be sold are from her holdings prior to the company's initial public offering and are unrestricted for trading [2]. - The estimated cashing out from this reduction, based on the latest share price of 12.52 yuan per share, could amount to approximately 3.88 million yuan [2]. Major Shareholder Activity - The largest shareholder, Jiangsu Baoyuan Investment Management Co., Ltd., previously executed a share reduction, selling 1,707,200 shares from August 25 to August 27, 2025, at an average price of 9.426 yuan per share, which reduced their holding from 144,584,000 shares to 142,926,800 shares, a decrease in ownership from 19.66% to 19.44% [3][4]. Financial Performance Forecast - Hongbaoli's 2025 annual report anticipates a net profit attributable to shareholders of 16 million to 24 million yuan, representing a year-on-year decline of 58.97% to 72.65%. The company expects a net loss of 10 million to 15 million yuan after excluding non-recurring gains and losses, compared to a profit of 33.76 million yuan in the previous year [4][5]. - The decline in profit is attributed to increased sales volume in new product markets, a decrease in raw material procurement prices leading to lower product prices, and a decline in gross profit margins due to currency fluctuations and impairment losses from project-related asset write-downs [5]. Market Performance - As of February 24, the company's stock price increased by 10.02% to 12.52 yuan per share, with a total market capitalization of 9.206 billion yuan [6].

Performance Summary - Supor reported a net profit of 2.097 billion yuan for 2025, a decrease of 6.58% year-on-year [2] - Sanofi reported a net profit of 2.939 billion yuan for 2025, an increase of 317.09% year-on-year [17] - Wens Foodstuff Group reported a net profit of 5.235 billion yuan for 2025, a decrease of 43.59% year-on-year [18] - Sree New Materials reported a net profit of 154 million yuan for 2025, an increase of 35.04% year-on-year [22] - JiaoKong Technology reported a net profit of 156 million yuan for 2025, an increase of 86.13% year-on-year [22] - Aidi Pharmaceutical reported a net loss of 19.7337 million yuan for 2025, a reduction in loss [22] - MicroGuide Nano reported a net profit of 213 million yuan for 2025, a decrease of 6.12% year-on-year [22] - Zhongwei Semiconductor reported a net profit of 285 million yuan for 2025, an increase of 108.05% year-on-year [22] - Hengyu Environmental reported a net profit of 35.9325 million yuan for 2025, an increase of 106.25% year-on-year [22] - Zhongke Shuguang reported a net profit attributable to shareholders of 2.113 billion yuan for 2025, an increase of 10.54% year-on-year [22] - Oat Technology reported a net profit of 137 million yuan for 2025, an increase of 42.63% year-on-year [22] - Yongxi Electronics reported a net profit attributable to shareholders of 82.2403 million yuan for 2025, an increase of 23.99% year-on-year [22] Shareholding Changes - Asia Optical's shareholders plan to reduce their holdings by no more than 1.6 million shares [22] - Anhui Conch Cement's controlling shareholder plans to increase its holdings by 700 million to 1.4 billion yuan [22] - Huaneng Hydropower's controlling shareholder plans to increase its holdings by 100 million to 150 million yuan [22] - Fushi Holdings' shareholders plan to reduce their holdings by no more than 2% [22] - Zhixin Precision's board members plan to reduce their holdings by no more than 1.8562% [22] - Hongbaoli's deputy general manager plans to reduce their holdings by no more than 310,000 shares [22] - Yuanli Co. plans to repurchase shares worth 50 million to 60 million yuan [22] - Zhongshun Jierou plans to repurchase shares worth 60 million to 120 million yuan [22] Contract Awards - Fengfan Co. won a procurement project from Southern Power Grid worth approximately 184 million yuan [22] - Shaoneng Co.'s wholly-owned subsidiary signed a cooperation agreement for land and resources for an independent energy storage power station project with Yuancan Company [22] Major Investments - Zhejiang Medicine plans to invest 250 million yuan in a silver economy fund in collaboration with a private equity fund [4] Project Approvals - Gansu Energy's Minqin Shuangchike 2 million kilowatt wind power project has been approved [5] - China Tianying received investment approval for the expansion of its Hanoi project [5] Mergers and Acquisitions - Dazhu Laser plans to invest 150 million USD to establish an overseas operation center [6] - Dongyang Sunshine is planning to acquire control of Dongshu No. 1, with stock suspension [6] - Shenlian Bio plans to acquire control of Shizhi Source for 237 million yuan to fully develop its innovative drug business [23] - Tongwei is planning to purchase 100% of Lihua Qingneng, with stock suspension starting tomorrow [23] - Changxin Bochuang plans to acquire 93.8108% of Shanghai Honghui Optical Communication Technology Co., Ltd. for 375 million yuan [23] - Kaipu Cloud has terminated the acquisition of 100% of Nanning Taike [23] Other Developments - Kexin Mechanical and Electrical obtained a production license for ultra-high pressure containers (A6) [10] - Baiyin Nonferrous Metals received a government subsidy of 9 million yuan [24] - Rundou Co. received a drug registration certificate for ibuprofen tablets [25] - Hengrui Medicine's application for the marketing authorization of the innovative drug SHR-1918 injection has been accepted and included in the priority review process [26] - Duorui Medicine's tender offer period has expired, and the company's stock is suspended [27] - Inner Mongolia Huadian plans to apply for a change of its stock name to "Huaneng Mengdian" [28]

证券代码：002165 证券简称：红宝丽 公告编号：临 2026-013 红宝丽集团股份有限公司关于 陶梅娟女士计划在本公告披露之日起15个交易日后的三个月内以集中竞价交易方 式减持公司股份不超过310,000股，占公司总股本不超过 0.04%。 红宝丽集团股份有限公司（以下简称"公司"或"红宝丽"）于近日收到公司副 总经理陶梅娟女士提交的《关于减持红宝丽部分股份计划的告知函》，现将相关情况 公告如下： 一、股东的基本情况 截至本公告日，本次减持主体持有公司股份情况如下： | 股东名称 | 股东身份 | 持股总数（股） | 占公司总股本比例 | | --- | --- | --- | --- | | 陶梅娟 | 高级管理人员 | 1,244,154 | 0.17% | 二、本次减持计划的主要内容 高级管理人员减持公司股份的预披露公告 高级管理人员陶梅娟保证向本公司提供的信息内容真实、准确、完整、无虚假记 载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 特别提示： 陶梅娟女士系公司副总经理，持有公司股份1,244,154 股，占公司总 ...

Group 1 - The company Hongbaoli (002165.SZ) announced that its Vice General Manager, Tao Meijuan, plans to reduce her shareholding by no more than 310,000 shares within three months after the announcement date, which accounts for no more than 0.04% of the company's total share capital [2]

Core Viewpoint - Hongbaoli (002165.SZ) expects a significant decline in net profit for 2025, projecting a decrease of 58.97% to 72.65% due to factors such as raw material prices, exchange rates, and impairment provisions for subsidiary projects [1][2]. Financial Performance - The company forecasts that the net profit attributable to shareholders for 2025 will range from 16 million to 24 million yuan, reflecting a year-on-year decline of 58.97% to 72.65% [2]. Project Development - Hongbaoli announced that its subsidiary, Taixing Chemical, has completed the necessary procedures for the epoxy propylene comprehensive technology renovation project, which has entered the preliminary preparation stage for trial production. However, there is uncertainty regarding the timeline from trial production to the output of qualified products [3]. Regulatory Situation - On December 12, 2025, Hongbaoli received a warning letter from the Jiangsu Securities Regulatory Bureau for failing to disclose related party fund occupation and errors in annual report data, and was criticized by the Shenzhen Stock Exchange. These violations have been recorded in the integrity archives of the securities and futures market [4].

Group 1 - The stock of Hongbaoli increased by 3.34% today, with a trading volume of 3.814 billion yuan and a turnover rate of 38.99% [1] - The Shenzhen Stock Connect special seat bought 187 million yuan and sold 77.27 million yuan, indicating significant trading activity [1] - Two institutional special seats net bought 19.89 million yuan, while two other institutional special seats net sold 103 million yuan, reflecting mixed institutional sentiment [1]